mercredi 14 octobre 2015

Onco Actu du 14 octobre 2015

2. Etiologie

Am I more likely to get cancer because I'm tall? [BBC News]

3.1 Tabac

Fresh Empire: FDA launches an Innovative Tobacco Public Education Campaign [FDA Voice]

5.12 Immunothérapies

It Takes Two to Tango: Combining Epigenetic Therapy and Immunotherapy [CANCER RESEARCH Catalyst]

5.2 Pharma

Artificial Intelligence, You Say? [In the Pipeline]

5.2.1 Pharma - Partenariats

Lilly and ImaginAb Announce Preclinical Immuno-Oncology Collaboration [Lilly]

Incyte and Merck Expand Clinical Collaboration to Include Phase 3 Study Investigating the Combination of Epacadostat with Keytruda® (pembrolizumab) as First-line Treatment for Advanced Melanoma [Merck]

5.2.3 Pharma - économie

Pfizer's CEO Faces The Drug Pricing Firestorm [Forbes]

5.3 Traitements - FDA, EMA,...

NICE launches initiative to speed up adoption of health technologies [NICE]

5.4 Traitements - Economie

Is This Cancer Treatment Worth It? New Tool Offers Patients Data [Bloomberg]

Four Reasons Drugs Are Expensive, Of Which Two Are False [Forbes]

6. Lutte contre les cancers

Human Longevity, Inc. Launches the Health Nucleus, a Comprehensive and Personalized Health Platform for Individuals [Human Longevity, Inc.]

ASCO Introduces New Online Genetics Toolkit [ASCO]

Does lack of physical exercise jeopardise a patient's chances of survival? [Cancer World]

6.1 Observation

Lack of referrals for suspected cancer leads to more deaths (Cancer Research UK]

Disparities in Breast Cancer Persist Across All Subtypes and Stages [AACR]

Thousands of cancer patients die needlessly due to referral delays [The Guardian]

Thousands of cancer patients dying because GPs fail to refer for tests [The Telegraph]

Cancer survivors often have poor diets [Reuters]

6.7 DMP, Big Data & applis

The Inevitability of Healthcare IT Interoperability: What We Learned From October 6th [The OBR Blog]

6.9 Controverses

Most animal research studies may not avoid key biases [Science]

Much of preclinical research into one cancer drug is flawed, says report [Retraction Watch]